000 | 01906 a2200529 4500 | ||
---|---|---|---|
005 | 20250517042408.0 | ||
264 | 0 | _c20160209 | |
008 | 201602s 0 0 eng d | ||
022 | _a1097-0215 | ||
024 | 7 |
_a10.1002/ijc.29686 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMathios, Dimitrios | |
245 | 0 | 0 |
_aTherapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model. _h[electronic resource] |
260 |
_bInternational journal of cancer _cJan 2016 |
||
300 |
_a187-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCentral Nervous System Neoplasms _ximmunology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlioblastoma _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunologic Memory |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aInterleukin-15 _xagonists |
650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
650 | 0 | 4 |
_aProteins _xpharmacology |
650 | 0 | 4 | _aRadiosurgery |
650 | 0 | 4 | _aRecombinant Fusion Proteins |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aPark, Chul-Kee | |
700 | 1 | _aMarcus, Warren D | |
700 | 1 | _aAlter, Sarah | |
700 | 1 | _aRhode, Peter R | |
700 | 1 | _aJeng, Emily K | |
700 | 1 | _aWong, Hing C | |
700 | 1 | _aPardoll, Drew M | |
700 | 1 | _aLim, Michael | |
773 | 0 |
_tInternational journal of cancer _gvol. 138 _gno. 1 _gp. 187-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.29686 _zAvailable from publisher's website |
999 |
_c25074463 _d25074463 |